A. Harmache et al., PRIMING WITH TAT-DELETED CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS (CAEV) PROVIRAL DNA OR LIVE VIRUS PROTECTS GOATS FROM CHALLENGE WITH PATHOGENIC CAEV, Journal of virology, 72(8), 1998, pp. 6796-6804
We previously reported that infection of goats with caprine arthritis
encephalitis virus (CAEV) tat- proviral DNA or virus results in persis
tent infection, since the animals seroconverted and direct virus isola
tion from cultures of blood derived macrophages was positive. In this
study we wanted to determine whether goats injected with CAEV tat- pro
viral DNA or virus were protected against challenge with the pathogeni
c homologous virus and to investigate whether CAEV tat- was still path
ogenic. All animals injected with CAEV tat- became infected as indicat
ed by seroconversion and virus isolation. Challenge at 8 or 9 months p
ostinfection demonstrated protection in four of four animals injected
with CAEV tat- but did not in three of three mock-inoculated challenge
d goats. Challenge virus was undetectable in the blood macrophages of
protected animals during a period of 6 or 10 months postchallenge. In
two of four protected animals, however, we were able to detect the cha
llenge wild-type virus by reverse transcriptase PCR on RNA directly ex
tracted from synovial membrane cells surrounding the inoculation site.
This result suggests that protection was achieved without complete st
erilizing immunity. Animals injected with CAEV tat- and mock challenge
d developed inflammatory lesions in the joints, although these lesions
were not as severe as those in CAEV wild-type-injected goats. These r
esults confirm the dispensable role of Tat in CAEV replication in vivo
for the establishment of infection and pathogenesis and demonstrate i
n another lentivirus infection model the efficacy of live attenuated v
iruses to induce resistance to superinfection.